| Effect of 12 mg vs 6 mg of dexamethasone on the number of days alive without life support in adults with COVID-19 and severe hypoxemia: the COVID STEROID 2 randomized trial L Russell, KR Uhre, ALS Lindgaard, JF Degn, M Wetterslev, P Sivapalan, ... Jama 326 (18), 1807-1817, 2021 | 233 | 2021 |
| An overview of mobile applications (apps) to support the coronavirus disease 2019 response in India A Bassi, S Arfin, O John, V Jha Indian Journal of Medical Research 151 (5), 468-473, 2020 | 105 | 2020 |
| Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial A Granholm, MW Munch, SN Myatra, BKT Vijayaraghavan, M Cronhjort, ... Intensive care medicine 48, 45-55, 2022 | 99 | 2022 |
| Current status and future directions of mHealth interventions for health system strengthening in India: systematic review A Bassi, O John, D Praveen, PK Maulik, R Panda, V Jha JMIR mHealth and uHealth 6 (10), e11440, 2018 | 63 | 2018 |
| Utilization, costs, and outcomes for patients receiving publicly funded hemodialysis in India M Shaikh, M Woodward, O John, A Bassi, S Jan, M Sahay, G Taduri, ... Kidney International 94 (3), 440-445, 2018 | 61 | 2018 |
| Tobacco control law enforcement and compliance in Odisha, India-Implications for tobacco control policy and practice B Panda, A Rout, S Pati, AS Chauhan, A Tripathy, R Shrivastava, A Bassi | 53 | 2012 |
| Higher vs lower doses of dexamethasone in patients with COVID‐19 and severe hypoxia (COVID STEROID 2) trial: Protocol and statistical analysis plan MW Munch, A Granholm, SN Myatra, BKT Vijayaraghavan, M Cronhjort, ... Acta Anaesthesiologica Scandinavica 65 (6), 834-845, 2021 | 26 | 2021 |
| Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia A Granholm, MBN Kjær, MW Munch, SN Myatra, BKT Vijayaraghavan, ... Intensive care medicine 48 (5), 580-589, 2022 | 22 | 2022 |
| Angiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive, multicentre, phase 3, randomised controlled trial MJ Jardine, SS Kotwal, A Bassi, C Hockham, M Jones, A Wilcox, ... Bmj 379, 2022 | 21 | 2022 |
| Challenges in operationalising clinical trials in India during the COVID-19 pandemic A Bassi, S Arfin, R Joshi, N Bathla, NE Hammond, D Rajbhandari, ... The Lancet Global Health 10 (3), e317-e319, 2022 | 15 | 2022 |
| Study to test and operationalize preventive approaches for CKD of undetermined etiology in Andhra Pradesh, India O John, B Gummidi, A Tewari, JP Muliyil, A Ghosh, M Sehgal, A Bassi, ... Kidney international reports 4 (10), 1412-1419, 2019 | 13 | 2019 |
| Higher vs lower doses of dexamethasone in patients with COVID‐19 and severe hypoxia (COVID STEROID 2) trial: protocol for a secondary Bayesian analysis A Granholm, MW Munch, SN Myatra, BKT Vijayaraghavan, M Cronhjort, ... Acta Anaesthesiologica Scandinavica 65 (5), 702-710, 2021 | 12 | 2021 |
| Hydroxychloroquine plus personal protective equipment versus standard personal protective equipment alone for the prevention of COVID-19 infections among frontline healthcare … BK Tirupakuzhi Vijayaraghavan, V Jha, D Rajbhandari, SN Myatra, ... Trials 21, 1-3, 2020 | 12 | 2020 |
| Hydroxychloroquine plus personal protective equipment versus personal protective equipment alone for the prevention of laboratory-confirmed COVID-19 infections among healthcare … TV BK, V Jha, D Rajbhandari, SN Myatra, A Ghosh, A Bhattacharya, ... BMJ open 12 (6), e059540-e059540, 2022 | 11 | 2022 |
| Protocol for the Controlled evaLuation of Angiotensin Receptor blockers for COVID-19 respIraTorY disease (CLARITY): a randomised controlled trial C Hockham, S Kotwal, A Wilcox, A Bassi, J McGree, C Pollock, LM Burrell, ... Trials 22 (1), 573, 2021 | 10 | 2021 |
| Relationship between measured and prescribed dialysate sodium in haemodialysis: a systematic review and meta-analysis JKC Ng, B Smyth, MR Marshall, A Kang, J Pinter, A Bassi, R Krishnasamy, ... Nephrology Dialysis Transplantation 36 (4), 695-703, 2021 | 9 | 2021 |
| Implementation of the framework convention on tobacco control (FCTC) in India (Health Related Information Dissemination Amongst Youth) KS Reddy, M Arora, R Shrivastav, A Yadav, D Singh, A Bassi Public Health Foundation of India (PHFI), New Delhi, India. http://www …, 2010 | 9 | 2010 |
| Implementation of the Framework Convention on Tobacco Control (FCTC) in India a Shadow Report—2010 KS Reddy, M Arora, R Shrivastav, A Yadav, D Singh, A Bassi New Delhi, India: HRIDAY and Framework Convention Alliance, 2010 | 9 | 2010 |
| The enforcement of India's tobacco control legislation in the state of Haryana: a case study D Jain, A Jadav, K Rhoten, A Bassi World Medical & Health Policy 6 (4), 331-346, 2014 | 7 | 2014 |
| Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxia: an international, randomized, blinded trial MW Munch, SN Myatra, BK Tirupakuzhi Vijayaraghavan, S Saseedharan, ... medRxiv, 2021.07. 22.21260755, 2021 | 6 | 2021 |
